Treatment Decisions for Patients with cancer during the cOVID-19 Pandemic

被引：2

作者：

Labaki, Chris ^{[1
]}

Peters, Solange ^{[2
]}

Choueiri, Toni K. ^{[1
,3
]}

机构：

[1] Dana Farber Canc Inst, 450 Brookline Ave, Boston, MA 02215 USA

[2] Lausanne Univ Hosp, Lausanne, Switzerland

[3] Harvard Med Sch, Boston, MA 02115 USA

来源：

CANCER DISCOVERY | 2021年 / 11卷 / 06期

关键词：

RISK-FACTORS; IMPACT; INFECTIONS; MANAGEMENT; MORTALITY; OUTCOMES; THERAPY; CARE;

D O I：

10.1158/2159-8290.CD-21-0210

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Patients with cancer have been disproportionally affected by the COVID-19 pandemic, with high rates of severe outcomes and death. Similarly, treatment decisions in this vulnerable population have been altered to a major degree during the past year, with significant disruption of care reported. Although complex, therapeutic choices in patients with cancer in times of COVID-19 are critical, as they may save thousands of lives. A mounting body of evidence, in addition to clear recommendations by multiple international societies, can help oncologists decide appropriately the necessity to administer antineoplastic regimens, helping to avoid a surge in cancer-related deaths in the upcoming months.

引用

页码：1330 / 1335

页数：6

共 40 条

[1] Determinants of the outcomes of patients with cancer infected with SARS-CoV-2: results from the Gustave Roussy cohort [J].

Albiges, Laurence ;

Foulon, Stephanie ;

Bayle, Arnaud ;

Gachot, Bertrand ;

Pommeret, Fanny ;

Willekens, Christophe ;

Stoclin, Annabelle ;

Merad, Mansouria ;

Griscelli, Frank ;

Lacroix, Ludovic ;

Netzer, Florence ;

Hueso, Thomas ;

Balleyguier, Corinne ;

Ammari, Samy ;

Colomba, Emeline ;

Baciarello, Giulia ;

Perret, Audrey ;

Hollebecque, Antoine ;

Hadoux, Julien ;

Michot, Jean-Marie ;

Chaput, Nathalie ;

Saada, Veronique ;

Hauchecorne, Mathilde ;

Micol, Jean-Baptiste ;

Sun, Roger ;

Valteau-Couanet, Dominique ;

Andre, Fabrice ;

Scotte, Florian ;

Besse, Benjamin ;

Soria, Jean-Charles ;

Barlesi, Fabrice .

NATURE CANCER, 2020, 1 (10) :965-+

[2] Upper respiratory viral infections in patients with haematological malignancies after allogeneic haematopoietic stem cell transplantation: a retrospective study [J].

Atilla, Erden ;

Sahin, Didem ;

Atilla, Pinar Ataca ;

Dolapci, Istar ;

Tekeli, Alper ;

Bozdag, Sinem Civriz ;

Yuksel, Meltem Kurt ;

Toprak, Selami Kocak ;

Ilhan, Osman ;

Arslan, Onder ;

Ozcan, Muhit ;

Gurman, Gunhan ;

Topcuoglu, Pervin .

ANTIVIRAL THERAPY, 2018, 23 (06) :523-527

[3]

Bakouny Z, 2020, JAMA ONCOL, V1, P2

[4]

Bange E, RES SQ, V2021

[5] Management of Respiratory Viral Infections in Hematopoietic Cell Transplant Recipients and Patients With Hematologic Malignancies [J].

Chemaly, Roy F. ;

Shah, Dimpy P. ;

Boeckh, Michael J. .

CLINICAL INFECTIOUS DISEASES, 2014, 59 :S344-S351

[6] COVID-19 and its implications for thrombosis and anticoagulation [J].

Connors, Jean M. ;

Levy, Jerrold H. .

BLOOD, 2020, 135 (23) :2033-2040

[7] Managing cancer patients during the COVID-19 pandemic: an ESMO multidisciplinary expert consensus [J].

Curigliano, G. ;

Banerjee, S. ;

Cervantes, A. ;

Garassino, M. C. ;

Garrido, P. ;

Girard, N. ;

Haanen, J. ;

Jordan, K. ;

Lordick, F. ;

Machiels, J. P. ;

Michielin, O. ;

Peters, S. ;

Tabernero, J. ;

Douillard, J. Y. ;

Pentheroudakis, G. .

ANNALS OF ONCOLOGY, 2020, 31 (10) :1320-1335

[8] COVID-19 in Immunocompromised Hosts: What We Know So Far [J].

Fung, Monica ;

Babik, Jennifer M. .

CLINICAL INFECTIOUS DISEASES, 2021, 72 (02) :340-350

[9] At the Crossroads: COVID-19 and Immune-Checkpoint Blockade for Cancer [J].

Garassino, Marina Chiara ;

Ribas, Antoni .

CANCER IMMUNOLOGY RESEARCH, 2021, 9 (03) :261-264

[10] COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study [J].

Garassino, Marina Chiara ;

Whisenant, Jennifer G. ;

Huang, Li-Ching ;

Trama, Annalisa ;

Torri, Valter ;

Agustoni, Francesco ;

Baena, Javier ;

Banna, Giuseppe ;

Berardi, Rossana ;

Bettini, Anna Cecilia ;

Bria, Emilio ;

Brighenti, Matteo ;

Cadranel, Jacques ;

De Toma, Alessandro ;

Chini, Claudio ;

Cortellini, Alessio ;

Felip, Enriqueta ;

Finocchiaro, Giovanna ;

Garrido, Pilar ;

Genova, Carlo ;

Giusti, Raffaele ;

Gregorc, Vanesa ;

Grossi, Francesco ;

Grosso, Federica ;

Intagliata, Salvatore ;

La Verde, Nicla ;

Liu, Stephen, V ;

Mazieres, Julien ;

Mercadante, Edoardo ;

Michielin, Olivier ;

Minuti, Gabriele ;

Moro-Sibilot, Denis ;

Pasello, Giulia ;

Passaro, Antonio ;

Scotti, Vieri ;

Solli, Piergiorgio ;

Stroppa, Elisa ;

Tiseo, Marcello ;

Viscardi, Giuseppe ;

Voltolini, Luca ;

Wu, Yi-Long ;

Zai, Silvia ;

Pancaldi, Vera ;

Dingemans, Anne-Marie ;

Van Meerbeeck, Jan ;

Barlesi, Fabrice ;

Wakelee, Heather ;

Peters, Solange ;

Horn, Leora .

LANCET ONCOLOGY, 2020, 21 (07) :914-922

← 1 2 3 4 →